PASCALE, Rosa Maria
 Distribuzione geografica
Continente #
NA - Nord America 6.426
AS - Asia 3.881
EU - Europa 2.411
SA - Sud America 2.252
AF - Africa 133
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 13
Totale 15.132
Nazione #
US - Stati Uniti d'America 6.260
BR - Brasile 2.035
SG - Singapore 1.661
CN - Cina 1.242
UA - Ucraina 826
DE - Germania 362
SE - Svezia 301
HK - Hong Kong 274
IT - Italia 239
FI - Finlandia 153
VN - Vietnam 148
GB - Regno Unito 132
TR - Turchia 131
FR - Francia 124
CA - Canada 73
AR - Argentina 65
IQ - Iraq 64
IN - India 54
CZ - Repubblica Ceca 52
MX - Messico 51
RU - Federazione Russa 48
ZA - Sudafrica 46
BE - Belgio 40
BD - Bangladesh 38
UZ - Uzbekistan 37
VE - Venezuela 36
EC - Ecuador 33
PK - Pakistan 31
ID - Indonesia 27
JP - Giappone 26
MA - Marocco 26
AT - Austria 25
PL - Polonia 21
CO - Colombia 20
IR - Iran 20
KR - Corea 20
AE - Emirati Arabi Uniti 19
PY - Paraguay 19
ES - Italia 18
JO - Giordania 15
LT - Lituania 15
AU - Australia 14
TN - Tunisia 14
CL - Cile 13
AZ - Azerbaigian 12
UY - Uruguay 12
EU - Europa 11
NP - Nepal 11
PE - Perù 11
KE - Kenya 9
NL - Olanda 9
PA - Panama 9
SN - Senegal 9
HN - Honduras 8
BG - Bulgaria 7
DZ - Algeria 7
JM - Giamaica 7
RO - Romania 7
BO - Bolivia 6
OM - Oman 6
DO - Repubblica Dominicana 5
EG - Egitto 5
IL - Israele 5
KZ - Kazakistan 5
SA - Arabia Saudita 5
AO - Angola 4
PS - Palestinian Territory 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
CI - Costa d'Avorio 3
EE - Estonia 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
PT - Portogallo 3
QA - Qatar 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
IE - Irlanda 2
ML - Mali 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
BF - Burkina Faso 1
BS - Bahamas 1
BY - Bielorussia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
Totale 15.116
Città #
Dallas 2.026
Chandler 955
Singapore 946
Jacksonville 488
Hong Kong 272
Princeton 272
Beijing 257
Dearborn 200
Nanjing 198
Ashburn 190
Ann Arbor 165
São Paulo 149
Wilmington 137
Sassari 128
Nanchang 101
Shanghai 93
Boardman 90
Los Angeles 87
Rio de Janeiro 82
Izmir 76
Ho Chi Minh City 62
Tianjin 56
Changsha 53
Santa Clara 53
Woodbridge 53
Shenyang 51
New York 49
Belo Horizonte 46
Brno 45
Munich 41
Brussels 40
The Dalles 40
Hebei 38
Jinan 38
Columbus 35
Council Bluffs 35
Tashkent 35
Baghdad 34
Toronto 34
Brasília 32
Jiaxing 32
Norwalk 30
Falls Church 29
Helsinki 27
Zhengzhou 27
Campinas 26
Hanoi 26
Porto Alegre 26
Hangzhou 25
Tokyo 25
London 24
Ningbo 24
Guangzhou 23
Mountain View 22
Buffalo 21
Curitiba 21
Johannesburg 21
Ribeirão Preto 20
San Francisco 20
Warsaw 20
Andover 19
Boston 19
Brooklyn 19
Nuremberg 19
Orem 19
San Jose 19
Seoul 19
Augusta 18
Denver 18
Goiânia 18
Kunming 18
Stockholm 18
Guarulhos 17
Salvador 17
San Mateo 17
Leawood 16
Montreal 16
Amman 15
Chennai 15
Praia Grande 15
Ardabil 14
Atlanta 14
Fortaleza 14
Mexico City 14
Santo André 14
Ankara 13
Guayaquil 13
Taizhou 13
Aracaju 12
Baku 12
Chicago 12
Houston 12
Lahore 12
Maceió 12
Monmouth Junction 12
Osasco 12
Pelotas 12
Recife 12
Sorocaba 12
Betim 11
Totale 8.874
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 328
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury 207
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 202
1-5-formyltetrahydrofolate and 1-5-methyltetrahydrofolate rescue in L-1210 leukemia treated with high methotrexate doses 200
5' Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon tetrachloride intoxication 188
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 170
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 169
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 166
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 164
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 162
Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosomine in the resistant BFF1 rat strain 162
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 162
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 160
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 160
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 160
An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling 155
Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 154
INHIBITION OF 3-HYDROXY-3-METHYLGLUTARY-COA REDUCTASE ACTIVITY AND GENE EXPRESSION BY DEHYDROEPIANDROSTERONE IN PRENEOPLASTIC LIVER NODULES 152
Chemoprevention of hepatocarcinogenesis: S.adenosyl-L-methionine 150
Amplification of c-myc oncogene in preneoplastic e neoplastic lesions induced in rat liver by the resistant hepatocyte protocol 149
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 142
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 141
Experimental models to define the genetic predisposition to liver cancer 141
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 140
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 137
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 136
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 135
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 134
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 133
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 133
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 132
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 132
Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma 130
New insights on the role of epigenetic alterations in hepatocellular carcinoma 128
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 127
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 126
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 125
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 124
Implication of Bcl 2 family genes in basal and D amphetamine induced apoptosis in preneoplastic and neoplastic rat liver lesions 124
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 124
S-Adenosylmethionine Regulates Apurinic/Apyrimidinic Endonuclease 1 Stability: Implication in Hepatocarcinogenesis 121
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma 121
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 120
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers 119
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 118
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 117
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/b-catenin pathway and progression of early lesions in the rat 117
THE BN RAT STRAIN CARRIES DOMINANT HEPATOCARCINOGEN RESISTANCE LOCI 117
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 116
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 116
Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats 116
Alterations of methionine metabolism as potential targets for the prevention and therapy of hepatocellular carcinoma 116
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 115
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 115
Blood cell count indexes of systemic inflammation in carotid artery disease: current evidence and future perspectives 115
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 115
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 115
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 114
Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report 112
Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10 109
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 109
Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene. 109
Genetic Control of Resistance to Hepatocarcinogenesis by the Mouse Hpcr3 Locus 107
Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts. 107
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC 107
Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. 107
Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System 106
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 106
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 106
S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. 105
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 105
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 104
DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma? 104
Persistent chemopreventive effect of S-adenosyl-L-methionine on the development of liver putative preneoplastic lesions induced by thiobenzamide in diethylnitrosamine-initiated rats 104
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 103
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 103
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 100
Decreased stimulation by 12-O-tetradecanoylphorbol-13-acetate of superoxide radical production by polymorphonuclear leukocytes carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 98
GENETIC AND EPIGENETIC CONTROL OF MOLECULAR ALTERATIONS IN HEPATOCELLULAR CARCINOMA 98
Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis. 98
Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats 94
The warburg effect 97 years after its discovery 94
Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5'-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma. 94
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 93
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 93
Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? 93
New putative prognostic markers and therapeutic targets for the molecular approach to treatment of hepatocellular carcinoma 93
Sulfatase 1: A new Jekyll and Hyde in hepatocellular carcinoma? 92
the role of S-adenosylmethionine in the regulation of glutathione pool and acetaldehyde production in acute ethanolintoxication 91
Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation. 89
Modulation of P16INK4 activity by HSP90, Cdc37 and CRM1 influences the progression of preneoplastico lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 88
Role of Dehydroepiandrosterone in Experimental and Human Carcinogenesis 86
Role of phosphatidylethanolamine methylation in the synthesis of phosphatidylcholine by hepatocytes isolated from choline-deficient rats. 85
Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. 85
Instabilità genomica nel carcinoma mammario 84
Inhibition of 3-hydroxy-3- methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneolastic liver nodules 84
INTERACTION OF MAJOR GENES PREDISPOSING TO HEPATOCELLULAR CARCINOMA WITH GENES ENCODING SIGNAL TRANSDUCTION PATHWAYS INFLUENCES TUMOR PHENOTYPE AND PROGNOSIS 84
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 83
Early stimulation of polyamine biosynthesis during promotion by phenobarbital of diethylnitrosamine-induced rat liver carcinogenesis. The effects of variations of the S-adenosyl-L-methionine cellular pooL 83
Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma 83
Totale 12.345
Categoria #
all - tutte 63.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021774 0 0 0 0 0 72 143 8 188 180 148 35
2021/2022784 116 8 6 11 24 33 45 46 73 42 84 296
2022/20231.658 179 147 43 293 152 279 0 189 278 6 57 35
2023/2024390 89 27 13 16 54 15 0 14 0 3 53 106
2024/20254.323 30 39 223 120 204 149 323 745 1.433 686 258 113
2025/20264.468 314 1.541 951 767 554 341 0 0 0 0 0 0
Totale 15.272